Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Structure-Activity Relationship of Dialkoxychalcones to Combat Fish Pathogen Saprolegnia australis.

Montenegro I, Muñoz O, Villena J, Werner E, Mellado M, Ramírez I, Caro N, Flores S, Madrid A.

Molecules. 2018 Jun 7;23(6). pii: E1377. doi: 10.3390/molecules23061377.

2.

Synthesis and Evaluation of Novel Oxyalkylated Derivatives of 2',4'-Dihydroxychalcone as Anti-Oomycete Agents against Bronopol Resistant Strains of Saprolegnia sp.

Flores S, Montenegro I, Villena J, Cuellar M, Werner E, Godoy P, Madrid A.

Int J Mol Sci. 2016 Aug 22;17(8). pii: E1366. doi: 10.3390/ijms17081366.

3.
4.

Hemi-Synthesis and Anti-Oomycete Activity of Analogues of Isocordoin.

Escobar B, Montenegro I, Villena J, Werner E, Godoy P, Olguín Y, Madrid A.

Molecules. 2017 Jun 10;22(6). pii: E968. doi: 10.3390/molecules22060968.

5.

Clotrimazole as a potent agent for treating the oomycete fish pathogen Saprolegnia parasitica through inhibition of sterol 14α-demethylase (CYP51).

Warrilow AG, Hull CM, Rolley NJ, Parker JE, Nes WD, Smith SN, Kelly DE, Kelly SL.

Appl Environ Microbiol. 2014 Oct;80(19):6154-66. doi: 10.1128/AEM.01195-14. Epub 2014 Aug 1.

6.

Molecular identification of a bronopol tolerant strain of Saprolegnia australis causing egg and fry mortality in farmed brown trout, Salmo trutta.

Rezinciuc S, Sandoval-Sierra JV, Diéguez-Uribeondo J.

Fungal Biol. 2014 Jul;118(7):591-600. doi: 10.1016/j.funbio.2013.11.011. Epub 2013 Dec 1.

PMID:
25088073
7.

The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans.

Wang YH, Dong HH, Zhao F, Wang J, Yan F, Jiang YY, Jin YS.

Bioorg Med Chem Lett. 2016 Jul 1;26(13):3098-3102. doi: 10.1016/j.bmcl.2016.05.013. Epub 2016 May 7.

PMID:
27210436
8.

Study of the antibacterial and antifungal activities of synthetic benzyl bromides, ketones, and corresponding chalcone derivatives.

Shakhatreh MA, Al-Smadi ML, Khabour OF, Shuaibu FA, Hussein EI, Alzoubi KH.

Drug Des Devel Ther. 2016 Nov 8;10:3653-3660. eCollection 2016.

9.

Antifungal activity, mechanism and QSAR studies on chalcones.

Sivakumar PM, Muthu Kumar T, Doble M.

Chem Biol Drug Des. 2009 Jul;74(1):68-79. doi: 10.1111/j.1747-0285.2009.00828.x.

PMID:
19519746
10.

Antifungal activity of chalcones: a mechanistic study using various yeast strains.

Lahtchev KL, Batovska DI, Parushev SP, Ubiyvovk VM, Sibirny AA.

Eur J Med Chem. 2008 Oct;43(10):2220-8. doi: 10.1016/j.ejmech.2007.12.027. Epub 2008 Jan 12.

PMID:
18280009
11.

Oridamycins A and B, anti-Saprolegnia parasitica indolosesquiterpenes isolated from Streptomyces sp. KS84.

Takada K, Kajiwara H, Imamura N.

J Nat Prod. 2010 Apr 23;73(4):698-701. doi: 10.1021/np1000522.

PMID:
20369841
12.

Thermal solvent-free synthesis of chromonyl chalcones, pyrazolines and their in vitro antibacterial, antifungal activities.

Siddiqui ZN, Praveen S, Musthafa TN, Ahmad A, Khan AU.

J Enzyme Inhib Med Chem. 2012 Feb;27(1):84-91. doi: 10.3109/14756366.2011.577035. Epub 2011 May 25.

PMID:
21612378
13.

Effects of fluconazole based medicated feed on haemato-immunological responses and resistance of Labeo rohita against Saprolegnia parasitica.

Saha H, Pal AK, Sahu NP, Saha RK, Goswami P.

Fish Shellfish Immunol. 2017 Dec;71:346-352. doi: 10.1016/j.fsi.2017.09.073. Epub 2017 Sep 28.

PMID:
28964864
14.

Synthesis, Characterization, Antimicrobial and Antioxidant Potential of Diazenyl Chalcones.

Kaur H, Narasimhan B.

Curr Top Med Chem. 2018;18(10):844-856. doi: 10.2174/1568026618666180626095714.

PMID:
29943703
15.

In vitro activity of chemicals and commercial products against Saprolegnia parasitica and Saprolegnia delica strains.

Tedesco P, Fioravanti ML, Galuppi R.

J Fish Dis. 2019 Feb;42(2):237-248. doi: 10.1111/jfd.12923. Epub 2018 Dec 10.

PMID:
30536642
16.

Design of potent fluoro-substituted chalcones as antimicrobial agents.

Burmaoglu S, Algul O, Gobek A, Aktas Anil D, Ulger M, Erturk BG, Kaplan E, Dogen A, Aslan G.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):490-495. doi: 10.1080/14756366.2016.1265517.

17.

Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.

Batovska D, Parushev S, Slavova A, Bankova V, Tsvetkova I, Ninova M, Najdenski H.

Eur J Med Chem. 2007 Jan;42(1):87-92. Epub 2006 Sep 26.

PMID:
17007965
18.

Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones.

Boeck P, Leal PC, Yunes RA, Filho VC, López S, Sortino M, Escalante A, Furlán RL, Zacchino S.

Arch Pharm (Weinheim). 2005 Mar;338(2-3):87-95.

PMID:
15799012
19.

Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.

Gibson MZ, Nguyen MA, Zingales SK.

Med Chem. 2018;14(4):333-343. doi: 10.2174/1573406413666171020121244.

PMID:
29065840
20.

Chitin synthases from Saprolegnia are involved in tip growth and represent a potential target for anti-oomycete drugs.

Guerriero G, Avino M, Zhou Q, Fugelstad J, Clergeot PH, Bulone V.

PLoS Pathog. 2010 Aug 26;6(8):e1001070. doi: 10.1371/journal.ppat.1001070.

Supplemental Content

Support Center